Identification
- Summary
Tragacanth is an extract from Tragacanth used in allergy testing.
- Generic Name
- Tragacanth
- DrugBank Accession Number
- DB10667
- Background
Tragacanth allergenic extract is used in allergenic testing.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Allergenics
Allergen Extract - Synonyms
- Astracantha adanica gum
- Astracantha gummifera gum
- Astragalus adanicus gum
- Astragalus adpressus gum
- Astragalus erianthus gum
- Astragalus gummifer gum
- Astragalus gummifer resin
- Astragalus noemiae gum
- Goat thorn bush resin
- Gum tragacanth
- Gum tragacanth milkvetch gum
- Gum tragacanth milkvetch resin
- Tragacanth
- Tragacanth allergenic extract
- Tragacanth gum
- Tragacanth milkvetch resin
- Tragacantha eriantha gum
- Tragacantha gummifera gum
- Tragacantha trojana gum
- External IDs
- E-413
- Fema no. 3079
- INS NO.413
- INS-413
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Tragacanth Gum Solution 0.001 g/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US 
Tragacanth Gum Solution 0.005 g/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US Tragacanth Gum Injection, solution 0.005 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Tragacanth Gum Injection, solution 0.01 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US
Categories
- Drug Categories
- Biological Products
- Biopolymers
- Carbohydrates
- Cell-mediated Immunity
- Complex Mixtures
- Compounds used in a research, industrial, or household setting
- Excipients
- Increased Histamine Release
- Increased IgG Production
- Macromolecular Substances
- Non-Standardized Food Allergenic Extract
- Non-Standardized Plant Allergenic Extract
- Pharmaceutic Aids
- Pharmaceutical Preparations
- Pharmaceutical Vehicles
- Plant Exudates
- Plant Gums
- Polymers
- Polysaccharides
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 2944357O2O
- CAS number
- 9000-65-1
References
- General References
- Not Available
- External Links
- PubChem Substance
- 347910805
- 1368197
- Wikipedia
- Tragacanth
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution Intradermal; Subcutaneous 0.005 g/1mL Injection, solution Intradermal; Subcutaneous 0.01 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.001 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.005 g/1mL - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:04 / Updated at June 12, 2020 16:53